Company · HCWB
HCW Biologics Inc.
Nasdaq's symbol directory lists HCWB on Nasdaq as “HCW Biologics Inc. - Common Stock”.
In the 12 months to Nov 8, 2026: insiders bought on 3 occasions ($100K); 3 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Hing C. Wong, Chief Executive Officer bought $60K
- Lee Flowers, SVP of Business Development bought $20K
- Scott T. Garrett bought $20K
Every trade (3)
- BUYHing C. Wong, Chief Executive Officer bought $60K
- BUYLee Flowers, SVP of Business Development bought $20K
- BUYScott T. Garrett bought $20K
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Entry into a material definitive agreement; Regulation FD disclosure; Other events Nov 5, 2026
- Entry into a material definitive agreement; Unregistered sales of equity securities; Regulation FD disclosure; Other events Sep 24, 2026
- Regulation FD disclosure; Other events Sep 10, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.